Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Predicting the Long-term Outcomes of Biologics in Psoriasis Patients using Machine Learning.

Emam S, Du AX, Surmanowicz P, Thomsen SF, Greiner R, Gniadecki R.

Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18741. [Epub ahead of print]

PMID:
31778205
2.

Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross-sectional study.

Yao Y, Jørgensen AR, Thomsen SF.

Int J Dermatol. 2019 Nov 17. doi: 10.1111/ijd.14706. [Epub ahead of print]

PMID:
31736064
3.

Clinical Management of Atopic Dermatitis in Adults: Mapping of Expert Opinion in 4 Nordic Countries using a Modified Delphi Process.

Thyssen JP, Berents T, Bradley M, Deleuran M, Grimstad Ø, Korhonen L, Langeland T, Särnhult T, Thomsen SF, Thune T, Wahlgren CF, Vestergaard C, von Kobyletzki LB, Remitz A.

Acta Derm Venereol. 2019 Nov 8. doi: 10.2340/00015555-3369. [Epub ahead of print]

4.

The prevalence of atopic dermatitis in adults: systematic review on population studies.

Mathiesen SM, Thomsen SF.

Dermatol Online J. 2019 Aug 15;25(8). pii: 13030/qt6nj0x5k0.

5.

The risk of asthma is increased among women with polycystic ovary syndrome: a twin study.

Zierau L, Meteran H, Backer V, Lindenberg S, Skytthe A, Thomsen SF.

ERJ Open Res. 2019 Sep 16;5(3). pii: 00018-2018. doi: 10.1183/23120541.00018-2018. eCollection 2019 Jul.

6.

Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease.

Jørgensen AR, Thomsen SF, Karmisholt KE, Ring HC.

Exp Dermatol. 2019 Sep 13. doi: 10.1111/exd.14036. [Epub ahead of print] Review.

PMID:
31519056
7.

Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital-based cohort study.

Jørgensen AR, Yao Y, Ghazanfar MN, Ring HC, Thomsen SF.

J Eur Acad Dermatol Venereol. 2019 Aug 23. doi: 10.1111/jdv.15904. [Epub ahead of print]

PMID:
31442338
8.

Atopic dermatitis is associated with increased use of social benefits: a register-based cohort study.

Slagor RM, Nørreslet LB, Ebbehøj NE, Bonde JP, Thomsen SF, Agner T.

J Eur Acad Dermatol Venereol. 2019 Aug 23. doi: 10.1111/jdv.15902. [Epub ahead of print]

PMID:
31442333
9.

Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection.

Saunte DML, Hare RK, Jørgensen KM, Jørgensen R, Deleuran M, Zachariae CO, Thomsen SF, Bjørnskov-Halkier L, Kofoed K, Arendrup MC.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01126-19. doi: 10.1128/AAC.01126-19. Print 2019 Oct.

PMID:
31383665
10.

Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis.

Ghazanfar MN, Karlsmark T, Danielsen PL, Thomsen SF.

Clin Case Rep. 2019 Jun 3;7(7):1350-1351. doi: 10.1002/ccr3.2225. eCollection 2019 Jul.

11.

Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study.

Thomsen SF, Skov L, Dodge R, Hedegaard MS, Kjellberg J.

Dermatology. 2019;235(5):372-379. doi: 10.1159/000499924. Epub 2019 Jun 25.

PMID:
31238322
12.

Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.

Chodziuk AC, Ghazanfar MN, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12902. doi: 10.1111/dth.12902. Epub 2019 Apr 23. No abstract available.

PMID:
30964569
13.

Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre.

Olesen CM, Holm JG, Nørreslet LB, Serup JV, Thomsen SF, Agner T.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1562-1568. doi: 10.1111/jdv.15609. Epub 2019 Apr 29.

PMID:
30959559
14.

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.

Humbert M, Bousquet J, Bachert C, Palomares O, Pfister P, Kottakis I, Jaumont X, Thomsen SF, Papadopoulos NG.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27. Review.

15.

Biologics for chronic inflammatory skin diseases: an update for the clinician.

Yao Y, Ravn Jørgensen AH, Thomsen SF.

J Dermatolog Treat. 2019 Mar 25:1-23. doi: 10.1080/09546634.2019.1589643. [Epub ahead of print]

PMID:
30827126
16.

Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Rasmussen SM, Brok J, Backer V, Thomsen SF, Meteran H.

COPD. 2018 Oct;15(5):526-535. doi: 10.1080/15412555.2018.1532495.

PMID:
30822245
17.

Isotretinoin and hidradenitis suppurativa.

Jørgensen AR, Thomsen SF, Ring HC.

Clin Exp Dermatol. 2019 Jun;44(4):e155-e156. doi: 10.1111/ced.13953. Epub 2019 Mar 21. No abstract available.

PMID:
30802991
18.

Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march.

Holm JG, Agner T, Clausen ML, Thomsen SF.

Arch Dermatol Res. 2019 Apr;311(3):173-182. doi: 10.1007/s00403-019-01895-z. Epub 2019 Feb 15.

PMID:
30770978
19.

Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department.

Holm JG, Clausen ML, Agner T, Thomsen SF.

Dermatology. 2019;235(3):189-195. doi: 10.1159/000496274. Epub 2019 Feb 13.

PMID:
30759429
20.

Omalizumab for atopic dermatitis: evidence for and against its use.

Holm JG, Thomsen SF.

G Ital Dermatol Venereol. 2019 Aug;154(4):480-487. doi: 10.23736/S0392-0488.19.06302-8. Epub 2019 Feb 4.

PMID:
30717578
21.

Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis.

Lund T, Sand C, Gniadecki R, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12846. doi: 10.1111/dth.12846. Epub 2019 Feb 22. No abstract available.

PMID:
30697879
22.

Type 2 diabetes and psoriasis: links and risks.

Holm JG, Thomsen SF.

Psoriasis (Auckl). 2019 Jan 17;9:1-6. doi: 10.2147/PTT.S159163. eCollection 2019. Review.

23.

D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review.

Ghazanfar MN, Thomsen SF.

Eur J Dermatol. 2018 Dec 1;28(6):731-735. doi: 10.1684/ejd.2018.3443. Review.

PMID:
30530404
24.

Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Vinkel C, Thomsen SF.

J Clin Aesthet Dermatol. 2018 Oct;11(10):17-23. Epub 2018 Oct 1. Review.

25.

Acne vulgaris in patients with hidradenitis suppurativa.

Ravn Jørgensen AH, Ring HC, Thomsen SF.

J Am Acad Dermatol. 2019 May;80(5):e129-e130. doi: 10.1016/j.jaad.2018.11.021. Epub 2018 Nov 17. No abstract available.

PMID:
30458210
26.

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study.

Zierau L, Cortes R, Thomsen SF, Jimenez-Solem E, Lindenberg S, Backer V.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00138-2017. doi: 10.1183/23120541.00138-2017. eCollection 2018 Oct.

27.

Self-reported intake of fruit and vegetables and risk of chronic obstructive pulmonary disease: A nation-wide twin study.

Meteran H, Thomsen SF, Miller MR, Hjelmborg J, Sigsgaard T, Backer V.

Respir Med. 2018 Nov;144:16-21. doi: 10.1016/j.rmed.2018.09.013. Epub 2018 Sep 20.

PMID:
30366579
28.

Clinical phenotypes of hidradenitis suppurativa.

Jørgensen AR, Thomsen SF, Ring HC.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e111-e112. doi: 10.1111/jdv.15276. Epub 2018 Oct 24. No abstract available.

PMID:
30288802
29.

Sample size estimation practices in research protocols submitted to Danish scientific ethics committees.

Flege MM, Thomsen SF.

Contemp Clin Trials Commun. 2018 Aug 15;11:165-169. doi: 10.1016/j.conctc.2018.08.003. eCollection 2018 Sep.

30.

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis.

Ghazanfar MN, Thomsen SF.

J Dermatolog Treat. 2019 Jun;30(4):387-388. doi: 10.1080/09546634.2018.1515465. Epub 2018 Sep 25.

PMID:
30132352
31.

Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review.

Ali Z, Ulrik CS, Agner T, Thomsen SF.

Dermatology. 2018;234(3-4):79-85. doi: 10.1159/000491593. Epub 2018 Aug 15. Review.

PMID:
30110673
32.

Cause-specific mortality in patients with psoriasis and psoriatic arthritis.

Skov L, Thomsen SF, Kristensen LE, Dodge R, Hedegaard MS, Kjellberg J.

Br J Dermatol. 2019 Jan;180(1):100-107. doi: 10.1111/bjd.16919. Epub 2018 Sep 26.

PMID:
29947129
33.

Patient expectations and determinants of patient satisfaction in a dermatology outpatient clinic.

Søndergaard MB, Ghazanfar MN, Thomsen SF.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e32-e33. doi: 10.1111/jdv.15144. Epub 2018 Jul 30. No abstract available.

PMID:
29923232
34.

Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa.

Jørgensen AR, Yao Y, Thomsen SF.

Case Rep Dermatol Med. 2018 Apr 16;2018:8685136. doi: 10.1155/2018/8685136. eCollection 2018.

35.

Comorbidities in vitiligo: comprehensive review.

Dahir AM, Thomsen SF.

Int J Dermatol. 2018 Oct;57(10):1157-1164. doi: 10.1111/ijd.14055. Epub 2018 May 28. Review.

PMID:
29808541
36.

The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review.

Johansen CB, Jimenez-Solem E, Haerskjold A, Sand FL, Thomsen SF.

Int J Mol Sci. 2018 May 3;19(5). pii: E1349. doi: 10.3390/ijms19051349. Review.

37.

Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.

Ghazanfar MN, Holm JG, Thomsen SF.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1761-1767. doi: 10.1111/jdv.15045. Epub 2018 May 29.

PMID:
29729103
38.

A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab.

Thomsen SF.

J Dermatolog Treat. 2018 Dec;29(8):823-824. doi: 10.1080/09546634.2018.1467537. Epub 2018 May 7. No abstract available.

PMID:
29671663
39.

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.

Li H, Yao Q, Mariscal AG, Wu X, Hülse J, Pedersen E, Helin K, Waisman A, Vinkel C, Thomsen SF, Avgustinova A, Benitah SA, Lovato P, Norsgaard H, Mortensen MS, Veng L, Rozell B, Brakebusch C.

Nat Commun. 2018 Apr 12;9(1):1420. doi: 10.1038/s41467-018-03704-z.

40.

A long-term follow-up study of the Hand Eczema Trial (HET): a randomized clinical trial of a secondary preventive programme introduced to Danish healthcare workers.

Graversgaard C, Agner T, Jemec GBE, Thomsen SF, Ibler KS.

Contact Dermatitis. 2018 May;78(5):329-334. doi: 10.1111/cod.12964. Epub 2018 Feb 26.

PMID:
29479726
41.

The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.

Yao Y, Thomsen SF.

Dermatol Online J. 2017 Jul 15;23(7). pii: 13030/qt8rw2j9zv. Review.

42.

Is atopic dermatitis associated with obesity? A systematic review of observational studies.

Ali Z, Suppli Ulrik C, Agner T, Thomsen SF.

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1246-1255. doi: 10.1111/jdv.14879. Epub 2018 Mar 9.

PMID:
29444366
43.

The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms.

Meteran H, Miller MR, Thomsen SF, Christensen K, Sigsgaard T, Backer V.

ERJ Open Res. 2017 Dec 8;3(4). pii: 00110-2017. doi: 10.1183/23120541.00110-2017. eCollection 2017 Oct.

44.

Transient hair loss in patients with chronic spontaneous urticaria treated with omalizumab.

Noshela Ghazanfar M, Thomsen SF.

Eur Ann Allergy Clin Immunol. 2017 Nov;49(6):284-285. doi: 10.23822/EurAnnACI.1764-1489.08.

45.

Pemphigoid gestationis: current perspectives.

Sävervall C, Sand FL, Thomsen SF.

Clin Cosmet Investig Dermatol. 2017 Nov 8;10:441-449. doi: 10.2147/CCID.S128144. eCollection 2017. Review.

46.

Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria.

Ferrer M, Boccon-Gibod I, Gonçalo M, İnalöz HS, Knulst A, Lapeere H, Parthasaradhi A, Stingl G, Tagka A, Valenzuela F, Yeung J, Thomsen SF.

Eur J Dermatol. 2017 Oct 1;27(5):455-463. doi: 10.1684/ejd.2017.3085.

PMID:
29084635
47.

An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts.

Larsen HK, Banzhaf CA, Thomsen SF, Gormsen M, Schopf RE, Haedersdal M.

J Eur Acad Dermatol Venereol. 2018 May;32(5):825-831. doi: 10.1111/jdv.14625. Epub 2018 Jan 23.

PMID:
29024025
48.

Response to omalizumab in patients with severe allergic asthma: A real-life study.

Zierau L, Walsted ES, Thomsen SF, Backer V.

Respir Med. 2017 Oct;131:109-113. doi: 10.1016/j.rmed.2017.08.011. Epub 2017 Aug 12.

PMID:
28947015
49.

Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study.

Schwensen JF, Clemmensen A, Sand C, Gniadecki R, Skov L, Zachariae C, Iversen L, Rasmussen M, Thomsen SF.

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12550. Epub 2017 Sep 14.

PMID:
28906051
50.

Institutional review boards' attitudes towards remuneration in paediatric research: Ethical considerations.

Flege MM, Thomsen SF.

J Paediatr Child Health. 2017 Dec;53(12):1149-1151. doi: 10.1111/jpc.13711. Epub 2017 Sep 14. Review.

PMID:
28905469

Supplemental Content

Loading ...
Support Center